MPI
Mannose-6-phosphate isomerase
Also known as: MPI_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P34949
- Gene
- MPI
- Ensembl
- ENSG00000178802
- Chromosome
- 15
- Canonical length
- 423 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
Phosphomannose isomerase catalyzes the interconversion of fructose-6-phosphate and mannose-6-phosphate and plays a critical role in maintaining the supply of D-mannose derivatives, which are required for most glycosylation reactions. Mutations in the MPI gene were found in patients with carbohydrate-deficient glycoprotein syndrome, type Ib. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
Canonical amino-acid sequenceUniProt
423 residues, UniProt reviewed canonical sequence.
>P34949|MPI
1 MAAPRVFPLS CAVQQYAWGK MGSNSEVARL LASSDPLAQI AEDKPYAELW MGTHPRGDAK
61 ILDNRISQKT LSQWIAENQD SLGSKVKDTF NGNLPFLFKV LSVETPLSIQ AHPNKELAEK
121 LHLQAPQHYP DANHKPEMAI ALTPFQGLCG FRPVEEIVTF LKKVPEFQFL IGDEAATHLK
181 QTMSHDSQAV ASSLQSCFSH LMKSEKKVVV EQLNLLVKRI SQQAAAGNNM EDIFGELLLQ
241 LHQQYPGDIG CFAIYFLNLL TLKPGEAMFL EANVPHAYLK GDCVECMACS DNTVRAGLTP
301 KFIDVPTLCE MLSYTPSSSK DRLFLPTRSQ EDPYLSIYDP PVPDFTIMKT EVPGSVTEYK
361 VLALDSASIL LMVQGTVIAS TPTTQTPIPL QRGGVLFIGA NESVSLKLTE PKDLLIFRAC
421 CLLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MPI can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 66 nTPM
Expression across tissuesHPA
Tissue
- tongue: 66 nTPM
- skeletal muscle: 49 nTPM
- adrenal gland: 47 nTPM
- cerebral cortex: 44 nTPM
- duodenum: 43 nTPM
- choroid plexus: 42 nTPM
Single-cell type
- cardiomyocytes: 171 nCPM
- esophageal apical cells: 70 nCPM
- enterocytes: 65 nCPM
- late primary spermatocytes: 60 nCPM
- late spermatids: 48 nCPM
- cytotrophoblasts: 40 nCPM
Immune cell
- naive CD4 T-cell: 56 nTPM
- T-reg: 53 nTPM
- NK-cell: 43 nTPM
- naive CD8 T-cell: 41 nTPM
- memory CD4 T-cell: 39 nTPM
- MAIT T-cell: 37 nTPM
Brain region
- pons: 62 nTPM
- medulla oblongata: 57 nTPM
- cerebellum: 54 nTPM
- midbrain: 51 nTPM
- thalamus: 49 nTPM
- hypothalamus: 45 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MPI.
Disease | AllUniProt
Conditions MPI is implicated in, by any mechanism.
- Congenital disorder of glycosylation 1B (CDG1B) MIM:602579
Disease | GeneticClinVar
148 pathogenic / likely-pathogenic of 615 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- MPI-congenital disorder of glycosylation
- MPI-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.17
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.15
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- GDP-D-mannose biosynthetic process from fructose-6-phosphate
- GDP-mannose biosynthetic process
- mannose to fructose-6-phosphate catabolic process
Molecular functions
- zinc ion binding
- mannose-6-phosphate isomerase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RmlC-like cupin domain superfamily
- RmlC-like jelly roll fold
- Mannose-6-phosphate isomerase, type I
- Mannose-6-phosphate isomerase
- Phosphomannose isomerase, type I, conserved site
- Phosphomannose isomerase type I, C-terminal domain
- Phosphomannose isomerase type I, catalytic domain
- Phosphomannose isomerase type I, helical insertion domain
- Phosphomannose isomerase type I C-terminal
- Phosphomannose isomerase type I, catalytic domain
- Phosphomannose isomerase type I, helical insertion domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MPI as an antibody target. Whether an autoantibody or antibody against MPI could matter depends on whether native MPI is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MPI is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MPI as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...